Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of TRK-130 in Patients With Overactive Bladder
jRCT2080220843Phase 2
- Sponsor
- Toray Industries
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of TRK-130 in overactive bladder (OAB), sponsored by Toray Industries.
02
Drugs
TRK-130
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2080220843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220843.